Clinical Trial Update: A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of Tapinarof Cream 1% in infants and toddlers (ages 3 months to <24 months) with atopic dermatitis i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tapinarof Cream 1% (tapinarof)

Snippet

Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 3 | Status: RECRUITING